Antineoplastic combinations of cci-779 and rituximab

Details Antineoplastic combinations of cci-779 and rituximab Antineoplastic combinations of cci-779 and rituximab

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/436 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2557005

This invention provides the use of a combination of CCI-779 and rituximab in the treatment of non-Hodgkin~s lymphoma.

L'invention concerne l'utilisation d'une combinaison de CCI-779 et de rituximab dans le traitement du lymphome non-hodgkinien.

Affiliated with

Also associated with

Rating

Antineoplastic combinations of cci-779 and rituximab does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antineoplastic combinations of cci-779 and rituximab, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antineoplastic combinations of cci-779 and rituximab will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1447977